Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3403
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03606174 | A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma | ||
| NCT04734860 | Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms | ||
| NCT05193227 | Sustained Release Lidocaine for the Treatment of Postoperative Pain | ||
| NCT07198724 | ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer | ||
| NCT01271374 | Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome | ||
| NCT06613360 | A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus | ||
| NCT06014762 | P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies | ||
| NCT02716246 | Phase I/II/III Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH | ||
| NCT02138396 | Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions | ||
| NCT03183141 | ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection | ||
| NCT00595920 | Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis | ||
| NCT06260527 | Safety and Pharmacokinetic Study of ARTS-011 in Chinese Healthy Volunteers | ||
| NCT07262268 | A Phase 1b Study of BHV-7000 in Participants With Inherited Erythromelalgia | ||
| NCT06431893 | A Phase 3 Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) | ||
| NCT01202149 | Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis | ||
| NCT07218640 | Aimmune Longitudinal Collaboration Study | ||
| NCT04330664 | Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2) | ||
| NCT07054684 | Study of BHV-1400 in IgA Nephropathy | ||
| NCT02279433 | A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b | ||
| NCT05417126 | Safety and Effects of a Single Intravitreal Injection of vMCO-010 Optogenetic Therapy in Subjects With Stargardt Disease | ||
| NCT01431833 | A PK and Safety Study in Subjects With Hepatic Impairment | ||
| NCT04872608 | A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer | ||
| NCT05511363 | A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1) | ||
| NCT03014635 | Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines | ||
| NCT01280344 | Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function | ||
| NCT05651932 | A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma | ||
| NCT00563563 | A Study of Naltrexone SR/ Bupropion SR in Overweight and Obese Subjects Who Are Nicotine-Dependent | ||
| NCT02998710 | Natural History Study of Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (ACAPPELLA) | ||
| NCT00795262 | Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension | ||
| NCT05668754 | Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH | ||
| NCT07580560 | Aqua Therapeutics Thermal Therapy Vapor Ablation System (ATTTVAS) Abnormal Uterine Bleeding Safety Study | ||
| NCT05431179 | A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma | ||
| NCT02447627 | Study of Methodologies to Measure Blood Flow and Oxygenation in Adults With Sickle Cell Disease | ||
| NCT04402541 | Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome | ||
| NCT02978222 | Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer | ||
| NCT07479979 | Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma | ||
| NCT03085173 | A Trial of "Armored" CAR T Cells Targeting CD19 For Patients With Relapsed CD19+ Hematologic Malignancies | ||
| NCT03051256 | Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD | ||
| NCT03538951 | Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis | ||
| NCT02429518 | Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis | ||
| NCT06672718 | A Study of SPY002-091 in Healthy Volunteers | ||
| NCT06136923 | An Exploratory Study to Evaluate Attention Biases in Adults With Multiple Sclerosis, Breast Cancer, and Lung Cancer | ||
| NCT06431373 | A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis | ||
| NCT03955783 | Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies | ||
| NCT02647853 | Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers | ||
| NCT06460844 | Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION) | ||
| NCT05225584 | Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors | ||
| NCT05948033 | CD70 Targeted CAR-T Cells in CD70 Positive Relapsed/Refractory Lymphoma | ||
| NCT07215832 | Karyopharm Expanded Access Program for Selinexor | ||
| NCT05867914 | Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD |
